Wednesday, June 18, 2025

Technology | 2021.05.01

Relmada Therapeutics Announces Poster Presentations at the American Psychiatric Association Annual Meeting 2021

NEW YORK, May 1, 2021 /PRNewswire/ -- Relmada Therapeutics, Inc. (Nasdaq: RLMD), a late-stage biotechnology company addressing diseases of the central nervous system (CNS), today announced that clinical data related to REL-1017, the company\'s lead product candidate, will be presented in...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]al-meeting-2021-301281575.html

You need to login to post comments.

Feed last updated 2025/06/30 @3:06 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News